Olfactory Biosciences Corp. is a life sciences company that focuses on designing products that contribute to better health using only natural phytochemicals and phytonutrients.

We bring true innovation to the health products market with an advanced delivery system, which delivers remedies developed by the Company to the olfactory receptors in the nose.

These receptors are the only nerves or neurotransmitters in our body that are exposed to the environment. They are attached to the olfactory bulb in our brain thereby providing immediate delivery to targeted areas in the brain.

Our History

The Company was formed in 1999 and focused on research and development of natural medicine products (Nutraceuticals) and Olfaction that can replace prescription chemical drugs. In that last few years, the company began to use the scientific discoveries related to olfactory receptors in the nose, described by two NOBEL Prize winners in medicine of 2004, Richard Axel and Linda Buck.

They were the first to organize and understand over two hundred olfactory receptors that are neurotransmitters to the brain (diagram below) and Our Company was and still is the first of its kind to use the new science to develop Nutraceuticals with natural ingredients in balms that are applied topically under the nose.

The Company’s gels using the new science of Nutraceuticals Olfaction can improve your quality of life and overcome complex behavioral challenges, addictions, insomnia and ADD to name a few.
Our Partner in Manufacturing


Flavor and Fragrance Specialties (FFS) provides the natural ingredients used in the company’s products and produces the gels proprietary blends for our company. FFS has the superior technical expertise that is necessary to produce our products. We recognize that the combined talent and enthusiasm of FFS employees is one of our most valuable resources. The FDA has approved FFS’s facility.

Our Science

Our company is excited about the possibilities we have discovered through the power of the olfactory system and want to share the amazing results with customers who will benefit from targeted, natural, over-the-counter solutions. We say that the solution to a higher quality of life is right under your nose. This is because all of our products have been designed to be inhaled in close proximity to your nasal openings.

Olfactory Biosciences Corp. is a public company trading OTC with the symbol OLFC.


Financial Reporting/Disclosure

Reporting StatusDark: Alternative Reporting Standard
Deregistered a/o May 14, 2003
Audited FinancialsNot Available
Fiscal Year End12/31
OTC MarketplaceOTCMarkets
Profile Data
SIC – Industry Classification8099 – Health and Natural Alternative Medications
Business Status​Marketing Topical
Alternative Medicines
Incorporated In:DE, USA
Year of Inc.1999
Employees10 a/o Apr 26, 2013


Company Officers/Contacts
Richard StevensonPresident, CEO
Sidney J. Pine​CFO, CPA
Victor SonderVP, Mkt. Advert
Dominicc Castaldo, DDSScience


Company Directors
​Jerry Brodsky, Chairman
Warren Chaney, PhD
Victor Sonder
Dominicc Castaldo, DDS
Sidney J Pine, CPA

Company Notes
Formerly=Adoodle, Inc. until 4-2010
Formerly=Glycology, Inc. until 6-07
Formerly=QuickTV, Inc. until 2-05
Service Providers
Accounting/Auditing Firm
Sidney J Pine, CPA
Legal Counsel
William Lerner, Esq.
Investor Relations Firm
World Stock Markets Group

Richard Stevenson
is a Director and President of the company. As a seasoned entrepreneur, Rick started several companies including The Stevenson Group, a full service fulfillment and distribution organization designed to meet the needs of Internet based retailers and wholesalers. OLFC acquired The Stevenson Group for stock. ” We have been in the unique position of verifying our products and getting them ready for our target markets. With our new team of Distributors around the world, I’m excited to lead our company and put our unique plan into motion”

Our Advisory Board

Dr. Warren H. Chaney is a Director of the company and is the Chief Executive Officer for Mind Technologies Dr. Chaney is recognized as one of the nation’s leaders in the area of ABS (Audio Brain Technology).

Myron Yanoff, M.D., currently is Professor and Chairman of the Department of Ophthalmology at Drexel University College of Medicine in Philadelphia PA, USA. He has been the recipient of one of the highest honors in American science − the Senior Distinguished U.S. Scientist Award (Humboldt-Award) In 1998.

Michael J. Stern is President of Stern Consulting LLC a company dedicated to assisting emerging growth companies. Mr. Stern also serves as an industry arbitrator for Finra.

Victor Sonder is a Director of the company and brings more than 30 years of experience and widely recognized skills in marketing and strategic planning, copywriting, art direction, film and video direction/production to his role as member of the company Advisory Board.

William Lerner, Esq. is the company’s SEC attorney and has been engaged in the private practice of corporate and securities law in New York for over 40 years.